University of Virginia School of Medicine scientists have uncovered a key reason why HIV remains so difficult to cure: Their research shows that small changes in the virus affect how quickly or slowly ...

Godfrey Dzhivhuho has dedicated his career to understanding HIV and other infectious diseases, inspired by the epidemic he witnessed growing up. Raised in Warrenton-Kimberly, South Africa, the oldest ...

Researchers at UVA School of Medicine have found long-sought answers to questions about HIV transmission, and the findings could lead to new ways to prevent the disease’s spread. More than 1 million ...

Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, ...

"HIV treatment is lifesaving but also lifelong," said Patrick Jackson, MD, one of the two lead authors on the paper. "Understanding how the virus stays latent in cells could help us develop a lasting ...

HIV is a lifelong infection that affects many people. People with HIV take many different types of medicines to help control their condition and to prevent the infection from developing into AIDS.

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent clinical trial, received a CAR T cell for your cancer, or even just taken ...

Beginning with an HIV diagnosis in 1990, Ivy Arce’s story spun into over three decades of activism, now unyielding in her demand for a cure. “For me, a cure is not a project,” she said. “Without ...

Gilead Sciences' new shot is a drug named lenacapavir, which was tested in two studies and reportedly eliminated HIV infections in high-risk patients. People have to test negative for HIV before they ...